Our People
Naren Basu
BSc, MBBS, MSc, MRCS (Ed), FRCS (Eng), MD, FEBS
Lead Consultant Oncoplastic Breast Surgeon
![Team member Image](https://birminghambreastgroup.com/wp-content/smush-webp/2024/04/Bio-Image.jpg.webp)
Personal Bio
Mr. Naren Basu is a distinguished Lead Consultant Oncoplastic Breast Surgeon at Birmingham Breast Group (BBG).
He was previously the Clinical Service Lead and Transformation lead overseeing the breast services at the Queen Elizabeth, Good Hope, and Solihull Hospitals, which constitute one of the largest breast care networks in the UK. He has recently taken on the post as NIHR Research Scholar to further research into Inflammatory Breast Cancer. The ultimate aim is to deliver the first clinical trial into this particular disease. He is the Principal Investigator in a number of national clinical trials including LORIS, POSNOC and SMALL. His is the Lead trainer in Birmingham for the Oncoplastic Breast Surgery Fellowship run by the Joint Committee on Surgical Training (JCST).
With a primary focus on breast care, cancer surgery, and oncoplastic techniques, Mr Basu seamlessly integrates plastic surgical methods into breast cancer treatment to achieve optimal aesthetic outcomes while ensuring effective disease control.
Naren’s journey into breast surgery began with his medical education at St Bartholomew’s and the Royal London Hospital, complemented by additional studies in Tumour Biology at University College London and a Master’s degree from Imperial College, London. He was awarded a First Class degree for his breast cancer research. His pursuit of excellence led him to prestigious institutions such as Harvard Medical and the Institut Curie, Paris, where he received advanced training.
Throughout his career, Naren has been recognised for his outstanding contributions to breast surgery. He was awarded the Ronald Raven Travelling Fellowship and a National Oncoplastic Fellowship, during which he conducted groundbreaking research on breast cancer risk factors, earning a doctorate from the University of Manchester. Naren’s research has significantly impacted clinical practice, leading to the formulation of the Manchester Guidelines and shaping risk-reducing surgery in high-risk patients. He has sub-specialty interest in Breast Cancer Genetics and completed post-graduate certification in Cancer Genetics at the Royal College of Physicians.
At BBG, Naren plays a pivotal role in providing exceptional patient care and advancing the field of breast surgery. As a leader in the multidisciplinary team, he collaborates with oncologists, radiologists, and other specialists to ensure comprehensive treatment plans tailored to each patient’s unique needs. Furthermore, Naren is actively involved in training the next generation of plastic and breast surgeons, both nationally and internationally. His role as an Honorary Senior Clinical Lecturer at the University of Birmingham underscores his commitment to education and mentorship, contributing to the ongoing advancement of breast care practices.
Specialist Treatments
Breast Reconstruction Autologous Breast Reconstruction Implant Skin Sparing Mastectomy / Skin Reducing Mastectomy / Nipple Sparing Mastectomy Therapeutic Mammoplasty Risk Reducing Mastectomy Genetic TestingPublished Work
Protocol for a multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammoplasty. Inter J of Surg Protocols 2016 Jan:1:3-10
A survey of oncoplastic breast surgeons in the England. Int J Surg Oncol M 2016 March: 1947876. doi: 10.1155/2016/1947876
Attitudes to contralateral risk reducing mastectomy amongst breast and plastic surgeons in England. Ann R Coll Surg Eng 2016 Feb; 98(2): 121-7
The Manchester guidelines for contralateral risk reducing mastectomy. World J Surg Oncol 2015 Aug:13: 237
Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis. Fam Cancer 2015 Dec:14(4);531-8
Sentinel lymph node biopsy in a patient with ruptured PIP implant. Int J Surg Case Rep. 2014;5(12):902-4
Threshold for genetic testing in women with breast cancer needs to be determined. BMJ 2014 March 6; 348
Prophylactic mastectomy and breast cancer. Br J Hosp Med. 2013 Oct:74(10):595
Mastectomies of healthy contralateral breast in patients with breast cancer. Br J Hosp Med 2013 Sept:74(9):486-7
An unusual case of rectal perforation resulting in extensive surgical emphysema. BMJ Case Rep. 2012
A 58-year-old man with epigastric pain and mass. BMJ Apr 21;340
Isolated duodenal ruptures due to go-karting accidents – braking news. Ann RCSEng. April 2009 – 91(4): 340-3
Morphine delays discharge in ambulatory surgery – a prospective institutional study. J Peri Prac. April 2009; 19(10): 312
Appendiceal polypectomy at Colonoscopy. Dig Surg. 2009 Mar 5;26(2):121-122
Tooth crown foreign body appendicitis. Dig Surg. 2009 Jan 21;26(1):22-23
Mobility one year after unilateral lower limb amputation: a modern UK institutional report. Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1024-6. Epub 2008 Aug 2
Use of Seamguard buttress suture in repair of staple line leak following laparoscopic gastric bypass for obesity. Obes Surg: 2008 Jul;18(7):896-7. Epub 2008 May 6
Large bowel obstruction due to gallstone: gallstone coleus. Grand Rounds (7) 36-3
The Abdominal Compartment Syndrome. Surgery 2006 (24) 260-2.
A stranger in the heart :vena caval stent migration. European Journal of Cardiothoracic Surgery. 2005 Nov;28(5):770. Epub 2005 Sep 26.